Inhibition of dipeptidyl peptidase (DPP)-4 stimulated CXCL12/CXCR4 expression and activated mTOR signaling, which further induced epithelial-mesenchymal transition of breast cancer cells and metastasis 39. Here, CXCL12 is linked to breast carcinoma.